Table 2 Treatment by setting for hyponatremia patients
| Â | Inpatient | ER | Office/Clinic |
|---|---|---|---|
Low Scenario (3.16 million prevalence; 1.17 million treated patients) | Â | Â | Â |
Overall | 63% (738,778) | 24% (280,988) | 13% (148,387) |
Acute and Symptomatic | 75% (23,679) | 25% (7,893) | 0% (0) |
Acute and Asymptomatic | 75% (94,715) | 25% (31,572) | 0% (0) |
Chronic and Symptomatic | 45% (241,524) | 45% (241,524) | 10% (53,672) |
Chronic and Asymptomatic | 80% (378,861) | 0% (0) | 20% (94,715) |
High Scenario (6.07 million prevalence; 1.35 million treated patients) | Â | Â | Â |
Overall | 55% (738,778) | 25% (333,070) | 20% (274,036) |
Acute and Symptomatic | 65% (35,530) | 35% (19,131) | 0% (0) |
Acute and Asymptomatic | 65% (106,590) | 35% (57,394) | 0% (0) |
Chronic and Symptomatic | 40% (256,544) | 40% (256,544) | 20% (128,272) |
Chronic and Asymptomatic | 70% (340,115) | 0% (0) | 30% (145,764) |